ANN
发表于 2025-3-28 15:43:00
http://reply.papertrans.cn/87/8698/869752/869752_41.png
PHON
发表于 2025-3-28 21:56:32
Mohammad A. Tayebi,Uwe Glässerte, the median survival rate for cisplatin-based first-line chemotherapy is 12–15 months, and the 5-year survival rate is about 15% (von der Maase et al., J Clin Oncol 23:4602–4608, 2005; von der Maase et al., J Clin Oncol 19:3068–3077, 2000). In addition, the results of second chemotherapy are limi
eczema
发表于 2025-3-29 02:20:11
http://reply.papertrans.cn/87/8698/869752/869752_43.png
指派
发表于 2025-3-29 04:12:01
Mohammad A. Tayebi,Uwe Glässerly FDA (Food and Drug Administration)-approved biomarkers for detection of UCC in bladder. Most of these novel biomarkers show higher sensitivity but lower specificity than conventional urine cytology. Thus, a study for finding another useful marker and improving shortcoming of currently available b